Differences in beta-glucan levels in culture supernatants of a variety of fungi

Medical Mycology

Volumn 44, Issue 3, 2006, Pages 267-272

  Odabasi, Zekaver ^a,c   Paetznick, Victor L ^a   Rodriguez, Jose R ^a   Chen, Enuo ^a   McGinnis, Michael R ^b   Ostrosky Zeichner, Luis ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Beta glucan; Diagnosis; Mould; Supernatant; Yeast

Indexed keywords

BETA 1,3 GLUCAN;

ABSIDIA; ACREMONIUM; ARTICLE; ASPERGILLUS; BASIDIOBOLUS; BIPOLARIS SPICIFERA; BLASTOSCHIZOMYCES CAPITATUS; CANDIDA; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CULTURE MEDIUM; CUNNINGHAMELLA; EXOPHIALA; FONSECAEA PEDROSOI; FUNGUS; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; HANSENULA ANOMALA; HYPHOMYCETES; IN VITRO STUDY; MADURELLA MYCETOMATIS; MUCOR; NONHUMAN; PAECILOMYCES; PENICILLIUM MARNEFFEI; PETRIELLIDIUM BOYDII; RHIZOMUCOR; RHIZOPUS; RHODOTORULA; SACCHAROMYCES CEREVISIAE; SCEDOSPORIUM; SCOPULORIOPSIS BREVICAULIS; SPECIES DIFFERENCE; SPOROTHRIX; SUPERNATANT; TRICHOSPORON ASAHII; WANGIELLA DERMATITIDIS;

BETA-GLUCANS; CULTURE MEDIA; FUNGI;

ABSIDIA; ACREMONIUM (ASCOMYCOTA); ASPERGILLUS; BASIDIOBOLUS; BIPOLARIS SPICIFERA; CANDIDA; CUNNINGHAMELLA; DIPODASCUS CAPITATUS; EXOPHIALA; EXOPHIALA DERMATITIDIS; FILOBASIDIELLA NEOFORMANS; FONSECAEA PEDROSOI; FUNGI; FUSARIUM; HYPHOMYCETES; MADURELLA MYCETOMATIS; MUCOR; PENICILLIUM MARNEFFEI; PICHIA ANOMALA; PSEUDALLESCHERIA BOYDII; RHIZOMUCOR; RHIZOPUS; RHODOTORULA (ERYTHROBASIDIUM CLADE); SACCHAROMYCES CEREVISIAE; SCEDOSPORIUM; SPOROTHRIX; TRICHOSPORON ASAHII;

EID: 33646847488     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500474327     Document Type: Article

References (21)

1. Fleming, RV and Walsh, TJ and Anaissie, EJ. (2002) Emerging and less common fungal pathogens Infect Dis Clin North Am, 16, pp. 915-933.
2. Marr, KA and Carter, RA and Crippa, F and Wald, A and Corey, L. (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients Clin Infect Dis, 34, pp. 909-917.
3. Morrison, VA and Haake, RJ and Weisdorf, DJ. (1993) The spectrum of non-Candida fungal infections following bone marrow transplantation Medicine (Baltimore), 72, pp. 78-89.
4. Ponton, J and Ruchel, R and Clemons, KV and (2000) Emerging pathogens Med Mycol, 38, pp. 225-236.
5. Silveira, F and Nucci, M. (2001) Emergence of black moulds in fungal disease: Epidemiology and therapy Curr Opin Infect Dis, 14, pp. 679-684.
6. Walsh, TJ and Groll, AH. (1999) Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century Transpl Infect Dis, 1, pp. 247-261.
7. Aisner, J and Wiernik, PH and Schimpff, SC. (1977) Treatment of invasive aspergillosis: Relation of early diagnosis and treatment to response Ann Int Med, 86, pp. 539-543.
8. Ohki, M and Nakamura, T and Morita, T and Iwanaga, S. (1980) A new endotoxin sensitive factor associated with hemolymph coagulation system of horseshoe crab (Limulidae) FEBS Lett, 120, pp. 217-220.
9. Morita, T and Tanaka, S and Nakamura, T and Iwanaga, S. (1981) A new (1-3)--β-D-glucan-mediated coagulation pathway found in limulus amebocytes FEBS Lett, 129, pp. 318-321.
10. Miyazaki T and Kohno, S and Mitsutake, K and (1995) (1→3)-beta-D-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor J Clin Lab Anal, 9, pp. 334-339.
11. Odabasi, Z and Mattiuzzi, G and Estey, E and (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome Clin Infect Dis, 39, pp. 199-205.
12. Obayashi, T and Yoshida, M and Mori, T and (1995) Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes Lancet, 345, pp. 17-20.
13. Mitsutake, K and Kohno, S and Miyazaki, T and (1995) Detection of (1-3)-beta-D-glucan in a rat model of aspergillosis J Clin Lab Anal, 9, pp. 119-122.
14. Miyazaki, T and Kohno, S and Mitsutake, K and (1995) Plasma (1-3)-b-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis J Clin Microbiol, 33, pp. 3115-3118.
15. Yoshida, M and Obayashi, T and Iwama, A and (1997) Detection of plasma (1-3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces, and Acremonium fungaemias J Med Vet Mycol, 35, pp. 371-374.
16. Yuasa, K and Goto, H and Iguchi, M and Okamura, T and Ieki, R. (1996) Evaluation of the diagnostic value of the measurement of (1-3)-beta-D-glucan in patients with pulmonary aspergillosis Respiration, 63, pp. 78-83.
17. Morimoto, S and Shimazaki, C and Goto, H and (1994) Trichosporon cutaneum fungemia in patients with acute myeloblastic leukemia and measurement of serum D-arabinitol, Candida antigen (CAND-TEC), and beta-D-glucan Ann Hematol, 68, pp. 159-161.
18. Jojima, H. (2001) Early diagnosis and treatment of pulmonary opportunistic infection by using polymerase chain reaction and beta-glucan in patients with hematological neoplasms Kurume Med J, 48, pp. 117-127.
19. SaekiF, RidgeRJ, FinkelmanMA, KetchumPA, RexJH. Application of a glucan-specific Limulus amebocyte lysate serum assay for diagnosis of invasive fungal infections. In: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy; 2001; abstract 841
20. Mori, T and Matsumura, M. (1999) Clinical evaluation of diagnostic methods using plasma and/or serum for three mycoses: Aspergillosis, candidosis, and pneumocystosis Nippon Ishinkin Gakkai Zasshi, 40, pp. 223-230.
21. Mori, T and Ikemoto, H and Matsumura, M and et al (1997) Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections Eur J Clinl Chem Clin Biochem, 35, pp. 553-560.